AIR GER Week ended 31 Jul 2026

Weekly Investor Report

Airbus SE · Industrials · Aerospace & Defense

Open interactive chart View report data
Latest close 202.2 EUR
-1.7% latest week
Weekly setup

Mixed setup

The weekly trend is active. Price is 10.3% above the Trend Line and sits at 76.1% of its 52-week range. The latest completed week returned -1.7%, after a -1.9% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks strongly; valuation is expensive relative to peers. The latest news-sentiment score is 52/100.

Setup score 52 out of 100
Latest Close 202.2 EUR 31 Jul 2026
1W Return -1.7% latest completed week
4W Return -1.9% short-term follow-through
12W Return 12.5% quarterly tape
Trend Breadth 53.8% 28 of 52 weeks active
Volume Ratio 1.4x vs 13-week average
What is working
  • The trend backdrop is active with a 1-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • Activity pressure is weak, so confirmation is not yet broad enough.
  • 2 reversal markers appear in the recent smart-money tape.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -1.7% Latest completed week; four-week move -1.9%. Indicator stack 33/75 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. News sentiment 52/100 14 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 10.3% above the Trend Line and sits at 76.1% of its 52-week range. The latest completed week returned -1.7%, after a -1.9% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.4x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.4312-week average 0.18

12-week confirmation

Trend active1/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure10/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership6/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.43Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers22 reversal markers

No recent accumulation markers. 2 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -1.9% over four weeks, 12.5% over 12 weeks, and 21.8% over one year. The current trend has remained active for 1 consecutive weeks.

Performance by holding period

1W-1.7%
4W-1.9%
12W12.5%
26W6.5%
52W21.8%
Active trend streak1 weeks
Active weeks in one year28
Trend breadth53.8%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure1.19Latest activity-pressure read.
Pressure change47.0%Four-week change in activity pressure.
Leadership2.29Latest relative-leadership reading.
RS change-46.6%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks strongly; valuation is expensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 94% Model confidence 90%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength11/100Blend of value, momentum, and quality. Underlying universe rank 90; rank 1 is best.
Value8/100Relative valuation strength. Underlying universe rank 93; rank 1 is best.
Quality42/100Profitability and accounting quality. Underlying universe rank 59; rank 1 is best.
Momentum66/100Medium-term price momentum. Underlying universe rank 35; rank 1 is best.
Growth83/100Revenue and earnings growth. Underlying universe rank 18; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework17/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
32.3x
Price divided by trailing earnings.
Price / sales
2.2x
Market value relative to trailing revenue.
EV / EBITDA
16.3x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
1.2%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
14.7%
Gross profit retained from each unit of revenue.
Operating margin
6.7%
Operating profit retained from revenue.
Free-cash-flow margin
2.6%
Free cash flow generated from revenue.
Return on invested capital
14.6%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
6.1%
Latest one-year revenue growth.
EPS growth
23.5%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
8.0%
Latest one-year free-cash-flow growth.
Piotroski F-score
8/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
1.6%
Cash dividends relative to market value.
Buyback yield
0.3%
Net share repurchases relative to market value.
Shareholder yield
1.9%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-0.1x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment52/100

Weighted news tone is neutral across 14 relevant articles.

2 positive · 12 neutral · 0 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-6.9%Distance below the 52-week high.
13-week volatility4.1%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher13 of 2613 weeks finished lower.
Best week+7.4%Week of 3 Jul.
Worst week-6.8%Week of 15 May.
Latest week-1.7%Week of 31 Jul.

Shape of recent returns

Strong gains6
Modest gains7
Flat weeks0
Modest losses7
Sharp losses6
Recent vol4.1%13-week weekly-return volatility.
Base vol3.6%52-week weekly-return volatility.
Up/down split28/24Count of positive and negative weeks in the 52-week window.
Average skew3.2% / -2.8%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape50/100

Trend, activity pressure, participation, and risk combine to a 50/100 tape read.

 Indicator analysis41/100

Latest 12-week confirmation: trend 1/12, activity pressure 10/12, relative leadership 6/12.

Activity pressure 0.43; 2 reversal markers Factors29/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 36 SVQF17/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 308.5 of 373 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment52/100

Weighted news tone is neutral across 14 relevant articles.

Frankfurt Stocks Close: Dax Shrugs Off Oil Price Rise, Airbus in Demand Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 2026202.2 EUR-1.7%183.4 EUR157.3 EUR1.192.291.5MOn
24 Jul 2026205.8 EUR5.9%183.3 EUR156.8 EUR1.196.501.4MOff
17 Jul 2026194.3 EUR-1.4%182.9 EUR156.3 EUR1.041.851.1MOff
10 Jul 2026197.1 EUR-4.4%182.8 EUR155.8 EUR0.992.441.3MOff
3 Jul 2026206.1 EUR7.4%182.6 EUR155.4 EUR0.814.291.4MOff
26 Jun 2026191.9 EUR1.3%182.2 EUR154.9 EUR0.531.65182.1KOff
19 Jun 2026189.5 EUR5.7%182.5 EUR154.4 EUR0.42-0.78851.1KOff
12 Jun 2026179.3 EUR0.1%182.8 EUR154.0 EUR0.23-4.67299.9KOff
5 Jun 2026179.0 EUR-0.3%183.6 EUR153.6 EUR0.05-5.15244.6KOff
29 May 2026179.6 EUR5.9%184.4 EUR153.3 EUR0.11-6.011.0MOff
22 May 2026169.7 EUR1.2%185.4 EUR152.9 EUR-0.08-10.331.5MOff
15 May 2026167.6 EUR-6.8%186.6 EUR152.6 EUR-0.41-7.861.3MOff
8 May 2026179.8 EUR2.8%187.6 EUR152.3 EUR-0.59-2.672.2MOff
1 May 2026174.8 EUR5.4%188.2 EUR151.9 EUR-1.05-4.981.4MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.